STOCK TITAN

Agilent Technologies Inc Stock Price, News & Analysis

A NYSE

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc (A) delivers cutting-edge analytical instruments and laboratory solutions for scientific advancement across biopharmaceutical, diagnostic, and environmental sectors. This page provides investors and industry professionals with a centralized source for all official company announcements and market-relevant developments.

Access real-time updates on Agilent's financial performance, strategic partnerships, product innovations, and regulatory milestones. Our curated news collection includes earnings releases, executive leadership updates, R&D breakthroughs, and industry event coverage—all essential for tracking the company's impact on life sciences and laboratory technology.

Key focus areas include advancements in genomic research tools, sustainability initiatives in lab operations, and cross-sector collaborations driving scientific discovery. Bookmark this page to stay informed about Agilent's evolving role in enabling precision medicine, environmental testing, and next-generation materials analysis.

Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) has received FDA approval for its content uniformity (CU) testing method utilizing the TRS100 Raman quantitative pharmaceutical analysis system. This approval, which specifically pertains to Teva Pharmaceutical Industries Ltd, marks a significant milestone for Agilent. The TRS100 system facilitates rapid analysis of active pharmaceutical ingredients (API) in tablets or capsules, enhancing quality control processes. The method’s FDA endorsement reduces risks related to adopting this technology, encouraging its implementation in manufacturing and quality control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
none
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) announced that its customer demonstration laboratory in Waldbronn, Germany, achieved the highest level of Green Lab Certification, indicating strong sustainability practices. This certification, recognized by the UN Race to Zero campaign, highlights Agilent's commitment to environmentally friendly operations in energy, water use, and waste management. This facility is the first of its kind for Agilent to receive this certification, with plans for additional labs to follow. The move aligns with Agilent's broader goals of achieving net-zero greenhouse gas emissions by 2050.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
none
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) announced its participation in Analytica 2022, taking place from June 21 to 24 in Munich, Germany. The company aims to showcase its latest innovations in mass spectrometry, including AI-driven instruments, which enhance lab productivity. Key products featured include the 6475 Triple Quadrupole LC/MS and 5977C GC/MSD, among others. Agilent emphasizes its commitment to sustainability through products labeled with My Green Lab ACT. Technical experts will be available for consultations at their booths, alongside hosting forum talks throughout the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) has announced the integration of its Alissa data analysis platform with NVIDIA's Clara Parabricks and Amazon EC2 G5g instances. This collaboration aims to enhance genomic data processing speeds, improving workflows for clinical labs and researchers. The integration supports Agilent's SureSelect NGS assays, allowing for cost-effective, targeted sequencing. The partnership with AWS focuses on leveraging global data security and cloud capabilities, enhancing efficiency and reducing analysis turnaround times for genomic experiments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) introduced new LC/MS and GC/MS mass spectrometers at the 70th ASMS Conference in Minneapolis, showcasing advancements in instrument intelligence that enhance lab operations. The Agilent 6475 triple quadrupole LC/MS offers improved analysis speed, while the 5977C GC/MSD introduces HydroInert technology for hydrogen use as a carrier gas. Agilent aims to facilitate sustainable lab choices through its partnership with My Green Lab. The company generated $6.32 billion in revenue in fiscal 2021, highlighting its strong market position in life sciences and diagnostics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) launched MassHunter BioConfirm 12.0 software, enhancing analysis for oligonucleotides in drug development. This update supports high-resolution LC/MS data, significantly improving oligonucleotide purity and sequence confirmation assessments. The software's new features allow researchers to confirm sequences in minutes instead of days, demonstrating Agilent's commitment to biopharma solutions. The software will be showcased at the 70th ASMS Conference in Minneapolis, from June 5-9, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
none
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) will participate in the Goldman Sachs 43rd Annual Healthcare Conference on June 15 in Rancho Palos Verdes, California. CEO Mike McMullen and CFO Bob McMahon will engage in a fireside chat starting at 10 a.m. PT (1 p.m. ET). Interested parties can access the live event via Agilent’s investor relations website, with a replay available within 24 hours. Agilent is a leader in life sciences and diagnostics, generating $6.32 billion in revenue in fiscal 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.88%
Tags
conferences
-
Rhea-AI Summary

Agilent Technologies Inc. (NYSE: A) announced the release of its IVDR Class A instruments, kits, and reagents on May 26, 2022, aligning with the EU's In Vitro Diagnostic Regulation (IVDR). This transition allows labs in the EU to use Agilent products without interruption, enhancing patient safety and regulatory compliance. Agilent's Class A products encompass a wide range of solutions, addressing challenges posed by the COVID pandemic. The company reported $6.32 billion in revenue for fiscal 2021 and boasts a global workforce of 17,000.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
none
News
Rhea-AI Summary

RTX A/S has announced the expansion of its audio module series supporting the Sheerlink product solutions during the NAMM show held in Anaheim, California from June 3-5, 2022. The new RTX1291 2.4GHz module enhances DSP performance, further solidifying RTX's position in providing resilient wireless audio solutions. This expansion allows vendors to streamline product development, addressing supply chain uncertainties. RTX continues to support a range of wireless configurations and offers complete ODM solutions to accelerate time-to-market for clients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.5%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $106.91 as of May 9, 2025.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 31.0B.
Agilent Technologies Inc

NYSE:A

A Rankings

A Stock Data

30.97B
284.18M
0.29%
91.65%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SANTA CLARA